RT Journal Article
SR Electronic
T1 Rapid inactivation of SARS-CoV-2 with LED irradiation of visible spectrum wavelenghts
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.18.20134577
DO 10.1101/2020.06.18.20134577
A1 R. De Santis
A1 V. Luca
A1 G. Faggioni
A1 S. Fillo
A1 P. Stefanelli
A1 G. Rezza
A1 F. Lista
YR 2020
UL http://medrxiv.org/content/early/2020/06/22/2020.06.18.20134577.abstract
AB The COVID-19 pandemic has caused a global health crisis. The difficulty to control the viral spread due to the absence of vaccines and prophylactics measures has raised concerns about prevention and control of SARS-CoV-2. Therefore, it becomes more and more crucial the reduction of environmental risk factors through viral inactivation of aerosols and fomites. Photodynamic inactivation of microorganisms by light energy emitted in the visible spectrum region (VIS), not harmful for mammalian cells and safe for humans, has recently been described. A LED-device emitting a special combination of frequencies in the visible light spectrum was tested on SARS-CoV-2 infected cell surnatant dilutions in order to evaluate the antiviral efficacy. This preliminary in vitro study showed for the first time the ability to inactivate SARS-CoV-2 through LED irradiation of visible spectrum wavelengths. If further and more extensive studies will confirm these data, the usage of this LED could potentially have a big impact on the sanitization of virtually all human environments.Competing Interest StatementThe authors have declared no competing interest.Funding Statementthe funds are from IT Minister of Defence of the current FY 2020Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The authors declare the exemption of the IRB/oversight bodyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthe Authors declare the data availability